NCT04777994 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04777994
Title	Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	AbbVie
Indications	gastric adenocarcinoma clear cell renal cell carcinoma lung non-small cell carcinoma head and neck squamous cell carcinoma Advanced Solid Tumor
Therapies	ABBV-CLS-484 + unspecified PD-1 antibody ABBV-CLS-484 ABBV-CLS-484 + unspecified VEGFR inhibitor
Age Groups:	adult \| senior
Covered Countries	USA \| ISR \| FRA \| ESP

NCT04777994
Clinical Trial Detail